Maitreya Medicare Ltd
Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]
- Market Cap ₹ 126 Cr.
- Current Price ₹ 186
- High / Low ₹ 308 / 153
- Stock P/E 788
- Book Value ₹ 46.4
- Dividend Yield 0.00 %
- ROCE 10.8 %
- ROE 7.17 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 55.93 | 49.35 | 39.28 | 46.08 | 44.98 | 46.00 | |
| 48.68 | 45.98 | 32.02 | 40.08 | 40.10 | 43.28 | |
| Operating Profit | 7.25 | 3.37 | 7.26 | 6.00 | 4.88 | 2.72 |
| OPM % | 12.96% | 6.83% | 18.48% | 13.02% | 10.85% | 5.91% |
| 0.43 | 0.33 | 0.53 | 0.30 | 0.57 | 0.63 | |
| Interest | 0.82 | 0.78 | 0.57 | 0.84 | 0.80 | 0.78 |
| Depreciation | 1.09 | 1.32 | 1.29 | 1.27 | 1.44 | 1.57 |
| Profit before tax | 5.77 | 1.60 | 5.93 | 4.19 | 3.21 | 1.00 |
| Tax % | 26.52% | 28.75% | 28.16% | 29.12% | 41.74% | |
| 4.24 | 1.14 | 4.25 | 2.97 | 1.87 | 0.16 | |
| EPS in Rs | 4,240.00 | 1,140.00 | 8.57 | 4.38 | 2.76 | 0.24 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -3% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| TTM: | -91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 18% |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 4.96 | 6.78 | 6.78 | 11.55 |
| Reserves | 3.85 | 4.70 | 3.81 | 18.07 | 19.94 | 19.91 |
| 14.24 | 12.38 | 11.59 | 11.10 | 10.53 | 4.28 | |
| 7.17 | 7.40 | 8.55 | 7.91 | 10.75 | 13.48 | |
| Total Liabilities | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 49.22 |
| 13.84 | 13.40 | 11.60 | 14.32 | 15.26 | 16.31 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.07 | 0.32 | 0.68 | 1.47 | 0.04 | 0.04 |
| 10.36 | 10.77 | 16.63 | 28.07 | 32.70 | 32.87 | |
| Total Assets | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 49.22 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 4.45 | 0.08 | 2.59 | -2.50 | 5.06 | |
| -5.07 | -0.02 | 0.36 | -5.44 | -7.37 | |
| 2.16 | -1.86 | -1.59 | 12.21 | 3.67 | |
| Net Cash Flow | 1.55 | -1.80 | 1.36 | 4.27 | 1.36 |
| Free Cash Flow | -1.17 | -0.82 | 3.16 | -4.11 | 2.68 |
| CFO/OP | 77% | 54% | 40% | -12% | 134% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 31.91 | 43.42 | 90.41 | 108.52 | 121.40 |
| Inventory Days | 68.78 | 40.82 | 69.86 | 40.26 | 36.56 |
| Days Payable | 258.06 | 221.84 | 319.59 | 207.25 | 199.54 |
| Cash Conversion Cycle | -157.37 | -137.61 | -159.32 | -58.47 | -41.58 |
| Working Capital Days | -4.11 | 3.11 | 43.12 | 73.43 | 73.68 |
| ROCE % | 12.33% | 32.85% | 17.30% | 10.77% |
Insights
In beta| Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Nov 2024 | Nov 2025 | |
|---|---|---|---|---|---|---|
| Number of Hospitals Number |
|
|||||
| Total Bed Capacity Number of Beds |
||||||
| Bed Capacity Utilization Percentage |
||||||
| OPD Capacity (Prannath Hospital) Visits per day ・Standalone data |
||||||
| OPD Capacity (Surat) Visits per day ・Standalone data |
||||||
| Operational Bed Capacity (Used) Number of Beds |
||||||
Extracted by Screener AI
Documents
Announcements
-
Shareholders meeting
20 April 2026 - Shareholders approved Maitreya Medicare’s Employee Stock Option Scheme 2026 by 100% postal ballot votes.
-
Updates
15 April 2026 - Maitreya Medicare not required to file Corporate Governance Report or Annual Secretarial Compliance Report for FY ended 31 Mar 2026.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
15 April 2026 - Maitreya Medicare says corporate governance report and secretarial compliance report are not applicable for FY2026.
-
Structural Digital Database
7 April 2026 - Submitted SDD compliance certificate for FY ended 31 March 2026; no non-compliance reported.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
7 April 2026 - Regulation 74(5) certificate received for quarter and year ended March 31, 2026.
Annual reports
Concalls
-
Nov 2025TranscriptAI SummaryPPT
-
Sep 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
Integrated Healthcare Provider[1] Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.